![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsors and Collaborators: |
The Lowy Medical Research Institute Limited None |
---|---|
Information provided by: | The Lowy Medical Research Institute Limited |
ClinicalTrials.gov Identifier: | NCT00568828 |
Earlier investigations have detected low levels of macular pigment (MP) in the center of the fovea and a halo of MP at a higher eccentricity in persons with type 2 idiopathic juxtafoveal teleangiectasia (MACTEL)[Helb H-M, Charbel Issa P, Pauleikhoff D, Scholl HPN, Holz FG, MacTel-Study Group. Macular Pigment Density and Distribution in Patients with Macular Telangiectasia. ARVO Annual Meeting 2006, Fort Lauderdale, 30.04.-5.05.2006. Program # 5701/B795]. To date it is not known whether the total MP is reduced in MACTEL or whether even more MP accumulates at higher eccenticities compared to healthy probands. With the suggested study we aim to
Condition |
---|
Macular Teleangiectasia Macular Pigment |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | Pilot Study to Evaluate the Changes of Macular Pigment Optical Density in Patients With Idiopathic Macular Teleangiectasia Following Supplementation of Lutein and Zeaxanthin |
Estimated Enrollment: | 12 |
Study Start Date: | December 2007 |
Estimated Study Completion Date: | February 2008 |
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
12 patients with Macular Teleangiectasia
Inclusion Criteria:
Exclusion Criteria:
Contact: Daniel Pauleikhoff, MD | 49-251-933080 | dapauleikhoff@muenster.de |
Germany | |
Dep. of Ophthalmology, St. Franziskus Hospital | Recruiting |
Muenster, Germany, 48145 | |
Contact: Meike Zeimer, MD 49-251-933080 kpl-auge@muenster.de |
Principal Investigator: | Daniel Pauleikhoff, MD | Chairman Dep. of Ophthalmology, St.Franziskus Hospital, Muenster, Germany |
Responsible Party: | Dep. of Ophthalmology, St. Franziskus Hospital, Muenster, Germany ( Daniel Pauleikhoff MD ) |
Study ID Numbers: | MacTEL Supplement, no |
Study First Received: | December 5, 2007 |
Last Updated: | December 5, 2007 |
ClinicalTrials.gov Identifier: | NCT00568828 History of Changes |
Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Macular Teleangiectasia Macular Pigment |